A TElmisartan and AMlodipine STudy to Assess the Cardiovascular PROTECTive Effects as Measured by Endothelial Dysfunction in Hypertensive at Risk Patients Beyond Blood Pressure.

Trial Profile

A TElmisartan and AMlodipine STudy to Assess the Cardiovascular PROTECTive Effects as Measured by Endothelial Dysfunction in Hypertensive at Risk Patients Beyond Blood Pressure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Mar 2015

At a glance

  • Drugs Amlodipine (Primary) ; Telmisartan (Primary) ; Hydrochlorothiazide; Olmesartan medoxomil
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms TEAMSTA PROTECT I; TEAMSTAprotect
  • Most Recent Events

    • 11 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 11 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top